TY  - CONF

T1  - LONG-TERM EFFICACY AND SAFETY OF DUPILUMAB IN A PHASE 3 OPEN-LABEL EXTENSION TRIAL (LIBERTY AD PED-OLE) IN PATIENTS AGED >= 6 TO < 12 YEARS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

JO  - ACTA DERMATO-VENEREOLOGICA

PY  - 2021/01/01

AU  - Cork MJ

AU  - Thaci D

AU  - Eichenfield LF

AU  - Arkwright PD

AU  - Chen Z

AU  - Prescilla R

AU  - Delevry D

AU  - O'Malley JT

AU  - Bansal A

ED  - 

VL  - 101

SP  - 60

EP  - 60

Y2  - 2024/12/22

ER  -